The Nasdaq, along with the S&P 500 and the Dow Jones Industrial Average, roared higher over the past two years, delivering ...

Invesco QQQ Trust ETF's valuation risks are high by historical standards. Read why QQQ is vulnerable to a hard landing due to ...

Shoe Carnival shifts focus to growth via rebranding and acquisitions while maintaining a strong balance sheet. Read my SCVL stock thesis.

BioStem's Q4-2024 revenue expected to rise 794% YoY, with full-year net revenue increasing 1,702%. Read why I'm bullish on ...

Nvidia’s ambitious AI roadmap unveiled at GTC could reshape Nasdaq Index sentiment, fueling optimism for tech stocks and ...

In investing, there's no need to invest in individual stocks to achieve strong returns over time. With that in mind, here are ...

The Pacer U.S. Large Cap Cash Cows Growth Leaders ETF (COWG) faces challenges, with high expenses, underperformance, and ...

In the above chart we have measured GE HealthCare Technologies' prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts ...

Learn More » This recession-forecasting tool was last wrong in 1966 At any given moment, there's bound to be one or more ...

SBPs may seem like a non-cash expense, but their impact on shareholder value is real. Discover how dilution affects long-term returns.

Vanguard FTSE Europe ETF (VGK) and Vanguard Total International Stock ETF (VXUS) are outperforming the S&P 500 in 2025.